Published in J Clin Microbiol on June 01, 1998
Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers. Scand J Gastroenterol (2012) 1.18
Age-dependent accuracy of Helicobacter pylori antibody assays for adults, with special emphasis on atrophic gastritis. Clin Diagn Lab Immunol (2004) 0.79
The Sydney System: histological division. J Gastroenterol Hepatol (1991) 5.49
Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet (1992) 4.54
Long-term sequelae of Helicobacter pylori gastritis. Lancet (1995) 4.26
Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology (1991) 3.38
Gastric precancerous process in a high risk population: cohort follow-up. Cancer Res (1990) 2.02
Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year follow-up study. Gastroenterology (1997) 1.67
Rapid eradication of Helicobacter pylori infection. Aliment Pharmacol Ther (1995) 1.61
Long-term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study. Scand J Gastroenterol (1996) 1.48
Kinetics of specific IgG antibodies for monitoring the effect of anti-Helicobacter pylori chemotherapy. J Infect Dis (1993) 1.05
Long-term follow-up of gastric histology after Helicobacter pylori eradication. J Gastroenterol Hepatol (1996) 1.03
Apparent reversal of early gastric mucosal atrophy after triple therapy for Helicobacter pylori. Am J Gastroenterol (1993) 0.93
Helicobacter pylori serology in chronic gastritis with antral atrophy and negative histology for Helicobacter-like organisms. J Clin Gastroenterol (1996) 0.89
Effect of eradication of Helicobacter pylori in patients with fundic atrophic gastritis. N Engl J Med (1997) 0.84
Successful Helicobacter pylori eradication incorporating a one-week antibiotic regimen. Aliment Pharmacol Ther (1995) 0.83
The Vienna classification of gastrointestinal epithelial neoplasia. Gut (2000) 9.39
Differences in diagnostic criteria for gastric carcinoma between Japanese and western pathologists. Lancet (1997) 7.59
Early antibiotic treatment in acute necrotising pancreatitis. Lancet (1995) 4.86
Differences in diagnostic criteria for esophageal squamous cell carcinoma between Japanese and Western pathologists. Cancer (2000) 4.55
Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet (1992) 4.54
Differences in the diagnostic criteria used by Japanese and Western pathologists to diagnose colorectal carcinoma. Cancer (1998) 3.98
Gastric dysplasia: the Padova international classification. Am J Surg Pathol (2000) 3.66
Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology (1991) 3.38
Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res (1997) 2.99
Doppler ultrasound examination of multiple sclerosis patients and control participants: inter-observer agreement and association with disease. Eur J Vasc Endovasc Surg (2013) 2.62
Stability of related human and chicken Campylobacter jejuni genotypes after passage through chick intestine studied by pulsed-field gel electrophoresis. Appl Environ Microbiol (1999) 2.38
Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am J Pathol (2000) 2.24
Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol (2003) 2.23
Demonstration of an intracellular copper-binding protein by orcein staining in long-standing cholestatic liver diseases. Gut (1976) 2.09
Prognosis of severe brain injury. Acta Neurol Scand (1970) 1.98
Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases. J Clin Pathol (1984) 1.98
Compositional analysis of Helicobacter pylori rough-form lipopolysaccharides. J Bacteriol (1992) 1.98
Campylobacter pylori in a sample of Finnish population: relations to morphology and functions of the gastric mucosa. Gut (1988) 1.98
Infections of the central nervous system of suspected viral origin: a collaborative study from Finland. J Neurovirol (2001) 1.96
Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther (2002) 1.94
Role of metronidazole resistance in therapy of Helicobacter pylori infections. Antimicrob Agents Chemother (1992) 1.92
Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer (1985) 1.89
CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease. Gut (2003) 1.87
Carcinoembryonic antigen in malignant and nonmalignant gynecologic tumors: circulating levels and tissue localization. Cancer (1978) 1.84
A three-year study of Campylobacter jejuni genotypes in humans with domestically acquired infections and in chicken samples from the Helsinki area. J Clin Microbiol (2000) 1.81
Helicobacter pylori infection and chronic gastritis in gastric cancer. J Clin Pathol (1992) 1.76
Detection and typing of Campylobacter jejuni and Campylobacter coli and analysis of indicator organisms in three waterborne outbreaks in Finland. Appl Environ Microbiol (2003) 1.75
Effects of supplemental alpha-tocopherol and beta-carotene on colorectal cancer: results from a controlled trial (Finland) Cancer Causes Control (2000) 1.75
Two years of Finnish Telestroke: thrombolysis at spokes equal to that at the hub. Neurology (2011) 1.75
Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings. Aliment Pharmacol Ther (2008) 1.72
Emergence of fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli in subjects from Finland. Antimicrob Agents Chemother (1991) 1.72
Enhanced expression of matrilysin, collagenase, and stromelysin-1 in gastrointestinal ulcers. Am J Pathol (1996) 1.72
Low biological activity of Helicobacter pylori lipopolysaccharide. Infect Immun (1992) 1.71
Procalcitonin strip test in the early detection of severe acute pancreatitis. Br J Surg (2001) 1.68
An acid extract as a common antigen in Campylobacter coli and Campylobacter jejuni strains. J Clin Microbiol (1983) 1.65
OLGA staging for gastritis: a tutorial. Dig Liver Dis (2008) 1.64
Serology of Campylobacter fetus ss. jejuni )"related" campylobacters). Demonstration of strain-specific and interstrain-related antigens by immunoelectrophoresis and co-agglutination. Acta Pathol Microbiol Scand B (1980) 1.64
A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. Aliment Pharmacol Ther (2005) 1.64
Helicobacter pylori induces lymphocyte activation in peripheral blood cultures. Clin Exp Immunol (1990) 1.62
Typing of human Campylobacter jejuni isolates in Finland by pulsed-field gel electrophoresis. J Clin Microbiol (1998) 1.59
Complications of negative laparotomy for truncal stab wounds. J Trauma (1995) 1.58
Migraine with aura is a risk factor for cervical artery dissection: a case-control study. Cerebrovasc Dis (2010) 1.57
Impact of clinical symptoms and referral volume on endoscopy for detecting peptic ulcer and gastric neoplasms. Scand J Gastroenterol (2003) 1.57
Differential expression of SPARC and thrombospondin 1 in wound repair: immunolocalization and in situ hybridization. J Histochem Cytochem (1993) 1.56
Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases. Br J Cancer (1984) 1.56
Gastric metaplasia and chronic inflammation at the duodenal bulb mucosa. Dig Liver Dis (2003) 1.55
Disappearance of gastritis after eradication of Helicobacter pylori. A morphometric study. Scand J Gastroenterol (1991) 1.53
A visual migraine aura locus maps to 9q21-q22. Neurology (2010) 1.52
Debulking or biopsy of malignant glioma in elderly people - a randomised study. Acta Neurochir (Wien) (2003) 1.52
Helicobacter antibodies in 1973 and 1994 in the adult population of Vammala, Finland. Epidemiol Infect (1997) 1.49
A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid. Gastroenterology (1995) 1.49
Long-term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study. Scand J Gastroenterol (1996) 1.48
Gastric cancer associated structure in mucus glycoproteins shown as a clinically useful marker. Gut (1991) 1.48
Intestinal metaplasia with colonic-type sulphomucins in the gastric mucosa; its association with gastric carcinoma. Acta Pathol Microbiol Scand A (1980) 1.47
Factors predicting interferon treatment response in patients with chronic hepatitis c: late viral clearance does not preclude a sustained response. Am J Gastroenterol (2001) 1.46
Chemical characterization of Campylobacter jejuni lipopolysaccharides containing N-acetylneuraminic acid and 2,3-diamino-2,3-dideoxy-D-glucose. J Bacteriol (1991) 1.46
Eletriptan vs sumatriptan: a double-blind, placebo-controlled, multiple migraine attack study. Neurology (2002) 1.46
Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia. Am J Gastroenterol (2001) 1.45
Apoptosis in different compartments of antrum and corpus mucosa in chronic Helicobacter pylori gastritis. An 18-year follow-up study. Scand J Gastroenterol (2001) 1.45
Patterns of matrix metalloproteinase and TIMP-1 expression in chronic and normally healing human cutaneous wounds. Br J Dermatol (1996) 1.44
Lactobacillus bacteremia, species identification, and antimicrobial susceptibility of 85 blood isolates. Clin Infect Dis (2006) 1.44
Evidence that cagA(+) Helicobacter pylori strains are disappearing more rapidly than cagA(-) strains. Gut (2002) 1.43
Follow-up of Helicobacter pylori positive gastritis and argyrophil cells pattern during the natural course of gastric ulcer. Helicobacter (1998) 1.41
Campylobacter enteritis in 188 hospitalized patients. Arch Intern Med (1983) 1.41
Prolonged campylobacter gastroenteritis in a patient with hypogammaglobulinaemia. Acta Med Scand (1983) 1.41
Incidence of Guillain-Barré syndrome during a nationwide oral poliovirus vaccine campaign. Neurology (1989) 1.41
Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage metalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations. Am J Pathol (1998) 1.38
Campylobacter-triggered reactive arthritis: a population-based study. Rheumatology (Oxford) (2002) 1.38
C-reactive protein (CRP) and serum phospholipase A2 in the assessment of the severity of acute pancreatitis. Gut (1987) 1.38
Atrophic chronic gastritis and intestinal metaplasia in gastric carcinoma. Comparison with a representative population sample. Cancer (1983) 1.36
Serology of Campylobacter fetus ss. jejuni. 2 Serotyping of live bacteria by slide, latex and co-agglutination tests. Acta Pathol Microbiol Immunol Scand B (1982) 1.30
Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics. Br J Cancer (2003) 1.30
Gastric polyps; their morphological and endoscopical characteristics and relation to gastric carcinoma. Acta Pathol Microbiol Immunol Scand A (1982) 1.29
Fecal bacteriology and reservoir ileitis in patients operated on for ulcerative colitis. Dis Colon Rectum (1988) 1.29
Reactive arthritis after campylobacter jejuni enteritis in patients with HLA-B27. Lancet (1980) 1.29
Transmission of vibration in the hand-arm system with special reference to changes in compression force and acceleration. Scand J Work Environ Health (1976) 1.28
Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms. Digestion (2000) 1.27
Arthritis associated with Campylobacter jejuni enteritis. Scand J Rheumatol (1981) 1.27
Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy--a placebo-controlled, double-blind randomized pilot study. Aliment Pharmacol Ther (2005) 1.25
Carpal tunnel syndrome in vibration disease. Br J Ind Med (1990) 1.24
Expression of cyclooxygenase-2 in dysplasia of the stomach and in intestinal-type gastric adenocarcinoma. Clin Cancer Res (2001) 1.24
Multicentre, randomised, double blind, placebo controlled, phase III study of weekly, low dose, subcutaneous interferon beta-1a in secondary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry (2004) 1.24
Chemotaxis in yersinia arthritis. HLA-B27 positive neutrophils show high stimulated motility in vitro. Arthritis Rheum (1980) 1.21
Decreasing trend of overlapping multilocus sequence types between human and chicken Campylobacter jejuni isolates over a decade in Finland. Appl Environ Microbiol (2010) 1.21
Genomic relatedness within five common Finnish Campylobacter jejuni pulsed-field gel electrophoresis genotypes studied by amplified fragment length polymorphism analysis, ribotyping, and serotyping. Appl Environ Microbiol (2001) 1.20
Orcein positive hepatocellular material in long-standing biliary diseases. I. Histochemical characteristics. Scand J Gastroenterol (1976) 1.20
Implications of serum pepsinogen I in early endoscopic diagnosis of gastric cancer and dysplasia. Helsinki Gastritis Study Group. Scand J Gastroenterol (2000) 1.19
Chronic gastritis: progression of inflammation and atrophy in a six-year endoscopic follow-up of a random sample of 142 Estonian urban subjects. Scand J Gastroenterol Suppl (1991) 1.18
Validation of a migraine-specific questionnaire for use in family studies. Eur J Neurol (2001) 1.18
Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer. Am J Epidemiol (1996) 1.18
Dysplasia and carcinoma in longstanding ulcerative colitis: an endoscopic and histological surveillance programme. Gut (1991) 1.16
Inverse correlation between Helicobacter pylori infection and inflammatory bowel disease. J Clin Pathol (1996) 1.16